Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection
9
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection Abstract Purpose: To evaluate pseudophakic cystoid macular edema (CME) by optical coherence tomography (OCT) and determine the efficacy of intravitreal triamcinolone acetonide injections. Methods: In this nonrandomized retrospective study, 10 eyes of 09 patients with persistent pseudophakic CME were treated with single triamcinolone acetonide injection and were followed up for 6 months . All patients underwent complete ophthalmologic examination including determination of best-corrected visual acuity, slit-lamp examination, tonometry, funduscopy and OCT recorded before and after 10, 20 days and 3 months the injection. Results: Visual acuity and value increased in all patients after intravitreal triamcinolone acetonide injections. OCT showed improvement of the retinal thickness in the macular area. There was no increase of intraocular pressure . Conclusion: Intravitreal triamcinolone acetonide injection is a promising therapeutic tool for chronic pseudophakic edema resistant other medical treatment. However, further study is needed to assess the treatment’s long-term efficacy, its safety, and the need for retreatment. There is no significant difference in the use of acrylic lenses and silicon lens in our results. Gonçalves CA..; Garcia, Marcos A..; Odloak CM. ;Campos, Paloma C.; Boro, Luiz Humberto T.; Miyamoto, Daniela A.; Going, Mayalu C. Retina Sector- Department of Ophthalmology Retina Sector- Department of Ophthalmology Ana Costa Hospital of Santos - HAC Ana Costa Hospital of Santos - HAC REFERENCES 1. Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Factors affecting pseudophakic macular edema. Five randomized trials. Am Intraocular Implant Soc S J. 1999;11:380-5. 2. Wright PL, Wilkinson CP, Balyeat HD, Popham J, Reinke M. Angiographic cystoid macullar edema after posterior chamber lens implantation. Arch Ophthalmol. 1988;106(6):740- 4. 3. Irvine SR. Cystoid maculopathy. Surv Ophthalmol. 1976;21:1-17. 4. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001;119:1380-3. . n AGE EYE RACE SEX BCVA BEFORE BCVA AFTER DISEASE S LIO TREATMENT TREATMENT 1 `78 OD WHITE MALE 20/80 20/20 DM ACRYLI C 2 65 OE WHITE FEMALE 20/100 20/30 NONE SILICO N 3 69 AO WHITE FEMALE 20/60 - 20/60 20/25 - 20/20 DM ACRYLI C 4 72 OE WHITE MALE 20/80 20/20 NONE ACRYLI C 5 81 OE WHITE MALE 20/70 20/25 DM ACRYLI C 6 70 OD WHITE MALE 20/60 20/25 NONE SILICO N 7 69 OE WHITE FEMALE 20/70 20/30 NONE SILICO N 8 80 OD WHITE MALE 20/80 20/20 NONE SILICO N 9 50 OD WHITE MALE 20/60 20/20 NONE ACRYLI C
description
. Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection. Gonçalves CA ..; Garcia, Marcos A..; Odloak CM. ; Campos, Paloma C.; Boro , Luiz Humberto T.; Miyamoto, Daniela A.; Going, Mayalu C. Retina Sector- Department of Ophthalmology - PowerPoint PPT Presentation
Transcript of Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection
Abstract
Purpose: To evaluate pseudophakic cystoid macular edema (CME) by optical coherence tomography (OCT) and determine the efficacy of intravitreal triamcinolone acetonide injections.
Methods: In this nonrandomized retrospective study, 10 eyes of 09 patients with persistent pseudophakic CME were treated with single triamcinolone acetonide injection and were followed up for 6 months . All patients underwent complete ophthalmologic examination including determination of best-corrected visual acuity, slit-lamp examination, tonometry, funduscopy and OCT recorded before and after 10, 20 days and 3 months the injection.
Results: Visual acuity and value increased in all patients after intravitreal triamcinolone acetonide injections. OCT showed improvement of the retinal thickness in the macular area. There was no increase of intraocular pressure .
Conclusion: Intravitreal triamcinolone acetonide injection is a promising therapeutic tool for chronic pseudophakic edema resistant to other medical treatment. However, further study is needed to assess the treatment’s long-term efficacy, its safety, and the need for retreatment. There is no significant difference in the use of acrylic lenses and silicon lens in our results.
Gonçalves CA..; Garcia, Marcos A..; Odloak CM. ;Campos, Paloma C.; Boro, Luiz Humberto T.; Miyamoto, Daniela A.; Going, Mayalu C.
Retina Sector- Department of OphthalmologyRetina Sector- Department of Ophthalmology Ana Costa Hospital of Santos - HACAna Costa Hospital of Santos - HAC
REFERENCES 1. Kraff MC, Sanders DR, Jampol LM, Lieberman HL. Factors affecting pseudophakic macular edema. Five randomized trials. Am Intraocular Implant Soc S J. 1999;11:380-5.2. Wright PL, Wilkinson CP, Balyeat HD, Popham J, Reinke M. Angiographic cystoid macullar edema after posterior chamber lens implantation. Arch Ophthalmol. 1988;106(6):740-4.3. Irvine SR. Cystoid maculopathy. Surv Ophthalmol. 1976;21:1-17. 4. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001;119:1380-3.
.
n AGE EYE RACE SEX BCVA BEFORE BCVA AFTER DISEASES LIO
TREATMENT TREATMENT
1 `78 OD WHITE MALE 20/80 20/20 DM ACRYLIC
2 65 OE WHITE FEMALE 20/100 20/30 NONE SILICON
3 69 AO WHITE FEMALE 20/60 - 20/60 20/25 - 20/20 DM ACRYLIC
4 72 OE WHITE MALE 20/80 20/20 NONE ACRYLIC
5 81 OE WHITE MALE 20/70 20/25 DM ACRYLIC
6 70 OD WHITE MALE 20/60 20/25 NONE SILICON
7 69 OE WHITE FEMALE 20/70 20/30 NONE SILICON
8 80 OD WHITE MALE 20/80 20/20 NONE SILICON
9 50 OD WHITE MALE 20/60 20/20 NONE ACRYLIC
Gonçalves CA.; Garcia,MA.; Odloak CM. ; Campos, PC.; Boro, LHT.; Miyamoto, DA.; Going, MC.
Retina Sector- Department of OphthalmologyRetina Sector- Department of Ophthalmology Ana Costa Ana Costa Hospital of Santos – HACHospital of Santos – HAC
There is no financial interest by the author and There is no financial interest by the author and coauthor’s in this poster issue.coauthor’s in this poster issue.
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone
Acetonide Injection
Purpose: To evaluate pseudophakic cystoid macular edema (CME) by optical coherence tomography (OCT) and determine the efficacy of intravitreal triamcinolone acetonide injections.
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone
Acetonide Injection
Methods: In this nonrandomized retrospective study, 10 eyes of 09 patients with persistent pseudophakic CME were treated with single triamcinolone acetonide injection and were followed up for 6 months . All patients underwent complete ophthalmologic examination including determination of best-corrected visual acuity, slit-lamp examination, tonometry, funduscopy and OCT recorded before and after 10, 20 days and 3 months the injection.
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone
Acetonide Injection
Results: Visual acuity and value increased in all patients after intravitreal triamcinolone acetonide injections. OCT showed improvement of the retinal thickness in the macular area. There was no increase of intraocular pressure. There is no significant difference in the use of acrylic lenses and silicon lens in our result
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone
Acetonide Injection
Conclusion: Intravitreal triamcinolone acetonide injection is a promising therapeutic tool for chronic pseudophakic edema resistant to other medical treatment. However, further study is needed to assess the treatment’s long-term efficacy, its safety, and the need for retreatment.
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone
Acetonide Injection
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone
Acetonide Injection
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone
Acetonide Injection
n AGE EYE RACE SEX BCVA BEFORE BCVA AFTER DISEASES LIO
TREATMENT TREATMENT
1 `78 OD WHITE MALE 20/80 20/20 DM ACRYLIC
2 65 OE WHITE FEMALE 20/100 20/30 NONE SILICON
3 69 AO WHITE FEMALE 20/60 - 20/60 20/25 - 20/20 DM ACRYLIC
4 72 OE WHITE MALE 20/80 20/20 NONE ACRYLIC
5 81 OE WHITE MALE 20/70 20/25 DM ACRYLIC
6 70 OD WHITE MALE 20/60 20/25 NONE SILICON
7 69 OE WHITE FEMALE 20/70 20/30 NONE SILICON
8 80 OD WHITE MALE 20/80 20/20 NONE SILICON
9 50 OD WHITE MALE 20/60 20/20 NONE ACRYLIC
Treatment of Pseudophakic CME with a Single Intravitreal Triamcinolone Acetonide Injection
![Efficacy of Triamcinolone Acetonide Extended-Release in ...The American College of Rheumatology (ACR) and the Osteoarthritis Research Society International [21, 22] recommend traditional](https://static.fdocuments.in/doc/165x107/5fb68d8752b34d7a6b770325/efficacy-of-triamcinolone-acetonide-extended-release-in-the-american-college.jpg)
